Literature DB >> 26754051

Boomerang: A method for recursive reclassification.

Sean M Devlin1, Irina Ostrovnaya2, Mithat Gönen2.   

Abstract

While there are many validated prognostic classifiers used in practice, often their accuracy is modest and heterogeneity in clinical outcomes exists in one or more risk subgroups. Newly available markers, such as genomic mutations, may be used to improve the accuracy of an existing classifier by reclassifying patients from a heterogenous group into a higher or lower risk category. The statistical tools typically applied to develop the initial classifiers are not easily adapted toward this reclassification goal. In this article, we develop a new method designed to refine an existing prognostic classifier by incorporating new markers. The two-stage algorithm called Boomerang first searches for modifications of the existing classifier that increase the overall predictive accuracy and then merges to a prespecified number of risk groups. Resampling techniques are proposed to assess the improvement in predictive accuracy when an independent validation data set is not available. The performance of the algorithm is assessed under various simulation scenarios where the marker frequency, degree of censoring, and total sample size are varied. The results suggest that the method selects few false positive markers and is able to improve the predictive accuracy of the classifier in many settings. Lastly, the method is illustrated on an acute myeloid leukemia data set where a new refined classifier incorporates four new mutations into the existing three category classifier and is validated on an independent data set.
© 2016, The International Biometric Society.

Entities:  

Keywords:  Predictive accuracy; Prognostication; Reclassification; Recursive partitioning; Survival analysis

Mesh:

Substances:

Year:  2016        PMID: 26754051      PMCID: PMC4940305          DOI: 10.1111/biom.12469

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  8 in total

1.  Whither TNM?

Authors:  Mithat Gönen; Martin R Weiser
Journal:  Semin Oncol       Date:  2010-02       Impact factor: 4.929

2.  Relative risk trees for censored survival data.

Authors:  M LeBlanc; J Crowley
Journal:  Biometrics       Date:  1992-06       Impact factor: 2.571

3.  Multiple myeloma. Clinical practice guidelines in oncology.

Authors:  Kenneth C Anderson; Melissa Alsina; William Bensinger; J Sybil Biermann; Asher Chanan-Khan; Raymond L Comenzo; Carlos M De Castro; Benjamin Djulbegovic; Sherif Farag; Carol Ann Huff; Ruby Meredith; Jeffrey Schriber; Dennis Shrieve; Seema Singhal; Mitchell R Smith; Keith Stockerl-Goldstein; Julie M Vose; Donna Weber; Joachim Yahalom; Furhan Yunus
Journal:  J Natl Compr Canc Netw       Date:  2007-02       Impact factor: 11.908

4.  The lasso method for variable selection in the Cox model.

Authors:  R Tibshirani
Journal:  Stat Med       Date:  1997-02-28       Impact factor: 2.373

5.  A comparison of estimators to evaluate the discriminatory power of time-to-event models.

Authors:  Matthias Schmid; Sergej Potapov
Journal:  Stat Med       Date:  2012-07-25       Impact factor: 2.373

6.  Exponential survival trees.

Authors:  R B Davis; J R Anderson
Journal:  Stat Med       Date:  1989-08       Impact factor: 2.373

7.  Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.

Authors:  M L Slovak; K J Kopecky; P A Cassileth; D H Harrington; K S Theil; A Mohamed; E Paietta; C L Willman; D R Head; J M Rowe; S J Forman; F R Appelbaum
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

8.  Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Authors:  Jay P Patel; Mithat Gönen; Maria E Figueroa; Hugo Fernandez; Zhuoxin Sun; Janis Racevskis; Pieter Van Vlierberghe; Igor Dolgalev; Sabrena Thomas; Olga Aminova; Kety Huberman; Janice Cheng; Agnes Viale; Nicholas D Socci; Adriana Heguy; Athena Cherry; Gail Vance; Rodney R Higgins; Rhett P Ketterling; Robert E Gallagher; Mark Litzow; Marcel R M van den Brink; Hillard M Lazarus; Jacob M Rowe; Selina Luger; Adolfo Ferrando; Elisabeth Paietta; Martin S Tallman; Ari Melnick; Omar Abdel-Wahab; Ross L Levine
Journal:  N Engl J Med       Date:  2012-03-14       Impact factor: 91.245

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.